IE39166L - N-substituted acetamide pharmaceuticals. - Google Patents

N-substituted acetamide pharmaceuticals.

Info

Publication number
IE39166L
IE39166L IE740542A IE54274A IE39166L IE 39166 L IE39166 L IE 39166L IE 740542 A IE740542 A IE 740542A IE 54274 A IE54274 A IE 54274A IE 39166 L IE39166 L IE 39166L
Authority
IE
Ireland
Prior art keywords
alkyl
acid
compounds
prepared
formula
Prior art date
Application number
IE740542A
Other versions
IE39166B1 (en
Original Assignee
Science Union & Cie
Fr De Rech Medicale Soc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Science Union & Cie, Fr De Rech Medicale Soc filed Critical Science Union & Cie
Publication of IE39166L publication Critical patent/IE39166L/en
Publication of IE39166B1 publication Critical patent/IE39166B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/08—Preparation of carboxylic acids or their salts, halides or anhydrides from nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • C07C57/38—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings polycyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/52—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen
    • C07C57/58—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

1436593 Substituted acetamides SCIENCE UNION ET CIE SOC FRANCAISE DE REMEDICALE 15 March 1974 [15 March 1973] 12430/73 Heading C2C Novel substituted acetamides of the Formula I in which R 1 is H or C 1 -C 6 alkyl; R 2 and R 3 each are C 1 -C 6 alkyl, cycloalkyl or aryl; R 6 is H or C 1 -C 6 alkyl; R 4 is H, C 1 -C 6 alkyl, C 2 -C 10 alkenyl or benzyl; R 5 is C 1 -C 6 alkyl, C 2 -C 10 alkenyl, C 2 -C 6 alkynyl or aryl-C 1 -C 4 alkyl; or R 4 and R 5 together with the nitrogen atom to which they are attached form a 5 to 8 membered saturated heterocyclic ring which is optionally substituted and may contain a further hetereo atom, and R<SP>1</SP> is H or acyl, and the acid addition salts thereof are prepared by reaction carboxylic acids of the formula or reactive functional derivatives thereof with amines of the formula compounds of the Formula I above in which R 4 is H may also be obtained by the hydrogenolysis or acid hydrolysis of the corresponding compounds in which R 4 is benzyl, and those in which R<SP>1</SP> is acyl by acylating the corresponding compounds in which R<SP>1</SP> is H. (2,2<SP>1</SP>,6,6<SP>1</SP> - Tetramethyldiphenyl)acetyl chloride is prepared by reacting thionyl chloride with the acid, resulting from the hydrolysis of the corresponding nitrile, which is made by reacting silver cyanide with (2,21,6,61-tetramethyldiphenyl)chloromethane. Similarly the following are prepared: (4,41 - difluorodiphenyl)acetyl chloride, (4,4<SP>1</SP> - difluorodiphenyl)acetic acid, and (4,4<SP>1</SP>-difluorodiphenyl)acetonitrile. Dicyclopropylacetyl chloride is prepared by reacting thionyl chloride with dicyclopropylacetic acid, obtained by oxidizing dicyclopropylacetaldehyde. (2,2<SP>1</SP>,3-Trimethoxy-5<SP>1</SP>-methyldiphenyl)acetic acid and (2-methoxy-2<SP>1</SP>-methylthio- 5<SP>1</SP>-methyldiphenyl)acetic acid are also obtained by oxidating the corresponding acetaldehydes. Pharmaceutical compositions, suitable for oral, parenteral, sublingual or rectal administration, contain the above compounds or non- toxic acid addition salts thereof in admixture or conjunction with pharmaceutical carriers. The compounds anti-arhythmic, cardio-depressive, vasodilatory, anti-hypertensive and anti-aggregating properties. [GB1436593A]
IE542/74A 1973-03-15 1974-03-14 N-substituted acetamides processes for their preparation and pharmaceutical compositions containing them IE39166B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1243073A GB1436593A (en) 1973-03-15 1973-03-15 N-substituted acetamides processes for their preparation and pharmaceutical compositions containing them apparatus for processing photograp

Publications (2)

Publication Number Publication Date
IE39166L true IE39166L (en) 1974-09-15
IE39166B1 IE39166B1 (en) 1978-08-16

Family

ID=10004460

Family Applications (1)

Application Number Title Priority Date Filing Date
IE542/74A IE39166B1 (en) 1973-03-15 1974-03-14 N-substituted acetamides processes for their preparation and pharmaceutical compositions containing them

Country Status (16)

Country Link
JP (1) JPS537406B2 (en)
AR (1) AR213712A1 (en)
AT (1) AT336579B (en)
AU (1) AU503812B2 (en)
BE (1) BE812339A (en)
CA (1) CA1052788A (en)
CH (1) CH583688A5 (en)
DE (1) DE2411885A1 (en)
ES (1) ES424238A1 (en)
FR (1) FR2221144B1 (en)
GB (1) GB1436593A (en)
HU (1) HU168559B (en)
IE (1) IE39166B1 (en)
NL (1) NL154496B (en)
SU (1) SU625600A3 (en)
ZA (1) ZA741711B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES469020A1 (en) * 1977-05-10 1979-09-01 Kali Chemie Pharma Gmbh N1-acyl-N2-phenyldiaminopropanols and pharmaceutical compositions thereof
DE2720915C2 (en) * 1977-05-10 1986-04-17 Kali-Chemie Pharma Gmbh, 3000 Hannover N? 1? -Acyl-2-hydroxy-1,3-diaminopropanes and drugs containing these compounds as an active ingredient
EP1640359A3 (en) * 1997-12-10 2006-04-05 Nps Pharmaceuticals, Inc. Anticonvulsant and central nervous system-active bis(fluorophenyl)alkylamides
WO2004094793A1 (en) 2003-04-24 2004-11-04 Byd Company Limited Muffler and catalytic converter devices

Also Published As

Publication number Publication date
AU503812B2 (en) 1979-09-20
AR213712A1 (en) 1979-03-15
NL7403543A (en) 1974-09-17
IE39166B1 (en) 1978-08-16
NL154496B (en) 1977-09-15
GB1436593A (en) 1976-05-19
SU625600A3 (en) 1978-09-25
FR2221144A1 (en) 1974-10-11
JPS49134619A (en) 1974-12-25
AT336579B (en) 1977-05-10
ZA741711B (en) 1975-04-30
ATA217874A (en) 1976-09-15
JPS537406B2 (en) 1978-03-17
CH583688A5 (en) 1977-01-14
AU6645874A (en) 1975-09-11
CA1052788A (en) 1979-04-17
FR2221144B1 (en) 1978-07-21
BE812339A (en) 1974-09-16
ES424238A1 (en) 1976-05-16
DE2411885A1 (en) 1974-09-26
HU168559B (en) 1976-05-28

Similar Documents

Publication Publication Date Title
GB1180749A (en) A New Polycyclic Amine and Processes for its Production
GB1465229A (en) Cyclic amino acids
IE821846L (en) Carbamimidoyl-1-carbadethiapen-2-em-3 carboxylic acid
IE40511B1 (en) N-(1-(-phenylalkyl)-piperidyl-j)-(-(-pyridyl)-carbonic acid amides
GB1358624A (en) Phenylacetic acid derivatives process for their preparation and applications thereof
GB1459065A (en) Therapeutic thiophene derivatives
IE39166L (en) N-substituted acetamide pharmaceuticals.
GB1398209A (en) Chromone derivatives
GB1314830A (en) Pharmaceutically useful benzomorphanes and their production
IE780901L (en) Tetrazolyl-piperidinyl amides
GB1240224A (en) Improvements in or relating to hydroxylamine derivatives
IE40825L (en) Ortho alkoxyanilides,a process for their preparation and pharmaceutical compositions containing them
JPS57144255A (en) Alpha-methylthio(1-alkyl-2-pyrrolyl)acetamide derivative
IE39770B1 (en) Thiazole derivatives
US3663711A (en) Methods for producing gastrointestinal antisecretory action
GB901942A (en) Imides
JPS5555160A (en) Preparation of substituted benzamide
GB1378419A (en) Phenylalanine derivatives
IE38377B1 (en) Maleopimarimide derivatives
GB1324687A (en) 3-amino-delta2-pyrazoline derivatives and process for the preparation thereof
GB1475234A (en) 4,5-azimidobenzamide derivative
GB1179262A (en) New Amides of Aliphatic Carboxylic Acids
GB1394366A (en) 2-aminothiophene derivatives
IE42625L (en) Thiazole 5-methanol derivatives
ES343093A1 (en) Basically substituted 2-imidazolidone derivatives and their production